NASDAQ:REPH

Recro Pharma SEC Filings & 10K Form

$2.76
-0.02 (-0.72 %)
(As of 04/16/2021 04:00 PM ET)
Add
Compare
Today's Range
$2.64
Now: $2.76
$2.80
50-Day Range
$2.54
MA: $3.37
$4.91
52-Week Range
$1.49
Now: $2.76
$9.19
Volume283,435 shs
Average Volume627,547 shs
Market Capitalization$85.60 million
P/E Ratio13.80
Dividend YieldN/A
Beta1.25

SEC Filings

Recro Pharma (NASDAQ:REPH) SEC Filings

DateFilerForm TypeView
04/15/2021
8:07 PM
HENWOOD GERALDINE (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2021
5:58 PM
Lake Ryan David (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2021
8:27 AM
Recro Pharma (Filer)
Form DEF 14A
03/15/2021
8:00 AM
Recro Pharma (Filer)
Form PRE 14A
02/26/2021
4:30 PM
Recro Pharma (Filer)
Form 424B5
02/26/2021
4:28 PM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2021
8:32 AM
Recro Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/26/2021
8:31 AM
Recro Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/26/2021
8:26 AM
Recro Pharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/26/2021
6:10 AM
Recro Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/26/2021
6:05 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/23/2021
7:16 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2021
4:49 PM
Miller James Charles (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2021
4:47 PM
Miller James Charles (Reporting)
Recro Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/12/2021
2:01 PM
Portolan Capital Management, LLC (Filed by)
Recro Pharma (Subject)
Form SC 13G/A
02/10/2021
11:14 AM
Recro Pharma (Subject)
RENAISSANCE TECHNOLOGIES LLC (Filed by)
Form SC 13G
02/01/2021
7:30 AM
BlackRock Inc. (Filed by)
Recro Pharma (Subject)
Form SC 13G/A
01/20/2021
6:56 PM
Lake Ryan David (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2021
6:54 PM
HENWOOD GERALDINE (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2021
4:18 PM
Lake Ryan David (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2020
12:52 PM
Portolan Capital Management, LLC (Filed by)
Recro Pharma (Subject)
Form SC 13G
12/28/2020
7:18 PM
Recro Pharma (Issuer)
SCP Vitalife Partners II, L.P. (0001602484) (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2020
7:18 PM
Recro Pharma (Issuer)
SCP Vitalife Partners II LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2020
6:53 PM
Recro Pharma (Issuer)
SCP Vitalife Partners II, L.P. (0001602484) (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2020
6:52 PM
Recro Pharma (Issuer)
SCP Vitalife Partners II LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2020
4:19 PM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2020
7:57 PM
Lake Ryan David (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
7:55 PM
ENLOE J DAVID JR (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
7:53 PM
ENLOE J DAVID JR (Reporting)
Recro Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/09/2020
4:44 PM
Lake Ryan David (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2020
4:43 PM
HENWOOD GERALDINE (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2020
6:11 AM
Recro Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/09/2020
6:05 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/22/2020
6:01 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2020
7:00 AM
Recro Pharma (Filer)
Form 424B5
08/10/2020
6:10 AM
Recro Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/10/2020
6:06 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2020
4:07 PM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2020
4:30 PM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2020
4:07 PM
Ajdler Arnaud (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2020
4:06 PM
Recro Pharma (Issuer)
Weisman Wayne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2020
4:05 PM
Reasons Bryan M. (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2020
6:31 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2020
6:01 AM
Recro Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/20/2020
6:42 PM
HENWOOD GERALDINE (Reporting)
Recro Pharma (Issuer)
Form 4/A
03/27/2020
4:29 PM
Recro Pharma (Filer)
Form DEF 14A
03/10/2020
3:25 PM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2020
6:32 AM
Recro Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/04/2020
6:01 AM
Recro Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/04/2020
6:00 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2020
4:45 PM
Lake Ryan David (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2020
4:44 PM
HENWOOD GERALDINE (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
3:51 PM
HENWOOD GERALDINE (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2019
3:40 PM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2019
6:47 PM
Flynn Karen (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2019
5:43 PM
Lake Ryan David (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2019
5:42 PM
Berelowitz Michael (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2019
5:38 PM
Ashton William (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2019
5:37 PM
ALTOMARI ALFRED (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2019
5:35 PM
CHURCHILL WINSTON J (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2019
5:29 PM
Reasons Bryan M. (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2019
5:28 PM
Recro Pharma (Issuer)
Weisman Wayne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2019
5:27 PM
HENWOOD GERALDINE (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2019
5:25 PM
Ajdler Arnaud (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2019
4:26 PM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2019
3:54 PM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2019
4:03 PM
Baudax Bio, Inc. (Issuer)
Recro Pharma (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2019
6:16 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
6:38 PM
Baudax Bio, Inc. (Issuer)
Recro Pharma (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/08/2019
6:11 AM
Recro Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2019
6:05 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2019
6:07 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2019
9:10 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2019
4:22 PM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2019
6:58 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2019
6:01 AM
Recro Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/07/2019
4:19 PM
Lake Ryan David (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:58 PM
BlackRock Inc. (Filed by)
Recro Pharma (Subject)
Form SC 13G/A
05/21/2019
3:11 PM
Ajdler Arnaud (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2019
7:52 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2019
3:30 PM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2019
3:06 PM
HENWOOD GERALDINE (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2019
9:43 AM
Flynn Karen (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
3:27 PM
CHURCHILL WINSTON J (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
3:26 PM
Recro Pharma (Issuer)
Weisman Wayne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
3:25 PM
Reasons Bryan M. (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
3:25 PM
Berelowitz Michael (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
3:24 PM
Ajdler Arnaud (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
1:50 PM
Recro Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2019
6:05 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2019
5:05 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2019
3:01 PM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2019
11:46 AM
Recro Pharma (Filer)
Form DEFA14A
03/28/2019
5:05 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2019
4:44 PM
Ajdler Arnaud (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2019
4:42 PM
Ajdler Arnaud (Reporting)
Recro Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/22/2019
3:17 PM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2019
11:16 PM
Recro Pharma (Filer)
Form EFFECT
03/20/2019
7:00 PM
Recro Pharma (Filer)
Form DEFA14A
03/20/2019
6:57 PM
Recro Pharma (Filer)
Form DEF 14A
This page was last updated on 4/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.